Drug Profile
Fibroblast growth factor-saporin mitotoxin
Alternative Names: FGF2-SAP; Fibroblast growth factor-saporin; PantarinLatest Information Update: 03 Jan 2001
Price :
$50
*
At a glance
- Originator Selective Genetics (CEASED)
- Class Anti-ischaemics; Antineoplastics; Growth factors; Vascular disorder therapies
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Eye disorders; Ischaemic heart disorders
Most Recent Events
- 03 Jan 2001 Discontinued-Preclinical for Cancer in USA (Unknown route)
- 03 Jan 2001 Discontinued-Preclinical for Eye disorders in USA (Unknown route)
- 03 Jan 2001 Discontinued-Preclinical for Ischaemic heart disorders in USA (Unknown route)